Log in with your email address username.


[Comment] Treating prediabetes in the obese: are GLP-1 analogues the answer?

Glucagon-like peptide 1 (GLP-1) analogues are increasingly recognised for their considerable clinical effects on weight loss and diabetes. Increasing evidence has shown their use can improve cardiovascular disease risk, decrease mortality, and provide other metabolic improvements.1